Trial Details
TERMINATEDBasic Information
| Clinical ID | c4593 |
|---|---|
| Identifier | NCT00279422 |
| Trial Title | A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: visilizumab|DRUG: visilizumab |
Participant Information
| Sponsor | Facet Biotech |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2006-02 |
|---|---|
| Primary Completion Date | 2007-08 |
| Completion Date | 2007-08 |